SALAMONE ALBERTO sold $1.2M of AEHR

SALAMONE ALBERTO (EVP, PPBI BUSINESS) sold 9,672 shares of AEHR TEST SYSTEMS (AEHR) at an average of $127.72 ($127.50–$128.00, $1.24M total) across 2 trades on 2026-08-13.

Original reporting
SEC EDGAR · SALAMONE ALBERTO
Published Aug 14, 2026, 6:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 6:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AEHR
Neutral
medium confidence
Mentioned
$AEHR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

The disclosure updates the record of insider activity and may influence short-term sentiment, but it does not change AEHR fundamentals based on the provided text.

02

Market read

Traders may monitor whether this sale is part of broader insider selling, but there is no new guidance, contract, or regulatory development in the text.

03

What to watch

The absence of a disclosed 10b5-1 plan can raise scrutiny, but the article does not provide context on prior grants, option exercises, or total insider selling cadence.

Relevance 6/10Novelty 5/10Timing: filed 2026-08-14 after-hours; transaction dated 2026-08-13

Background

This is an SEC Form 4 insider transaction disclosure for AEHR, reported by EVP Alberto Salamone.

Company-level read

Ticker impact

$AEHRNeutralMedium confidence
Context

AEHR insider Form 4 shows EVP Alberto Salamone sold 9,672 shares in open-market trades for about $1.24M on 2026-08-13.

Expected impact

Low near-term impact; any reaction is likely sentiment-driven and limited unless follow-on selling accelerates.

Evidence & confidence

The filing is a primary-source Form 4, but it provides no new company-specific operational or financial information, and insider sales are often non-informational.

Market effects

No sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the signal may be overstated.

Key entities

  • AEHR

    AEHR Test Systems, the company whose insider transaction is disclosed.

  • Alberto Salamone

    EVP, PPBI Business, who sold 9,672 shares in open-market trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AEHRHighAI 9/10

Aehr Test Systems (AEHR) (Q1 2027) Earnings Call Highlights: Record Revenue, Raised

Aehr Test Systems (AEHR) reported record Q1 2027 revenue of $33M and raised annual guidance to $150M. CEO Gayn Erickson highlighted a potential large burn-in opportunity, estimating $35M-$70M in revenue per million units shipped. The company expects sequential growth in remaining quarters, with Q4 potentially the highest. Management confirmed they are not supply-constrained and can ship more than guided. Silicon carbide revenue was about $10M in fiscal 2026, with expectations for growth in 2027.

$AEHRHighAI 9/10

AEHR Stock Surges After Massive AI-Driven Earnings Beat

Aehr Test Systems (AEHR) stock rose 26.6% after reporting Q1 FY27 revenue of $33M, up 300% year-over-year and 75% quarter-over-quarter. Adjusted EPS was $0.28, beating estimates. The company raised FY27 revenue guidance to $150M, citing strong demand for AI and power semiconductor testing.

$AEHRHighAI 9/10

Aehr Stock Jumps 16% After Bookings Hit $46.7 Million

Aehr Test Systems (AEHR) shares rose 16.38% premarket after its Q1 revenue tripled to $33.0M, beating estimates. The company raised its full-year outlook to $150M, citing strong bookings and backlog growth. CEO Gayn Erickson highlighted a major AI customer opportunity. According to GuruFocus, there are 6 warning signs with AEHR.

$AEHRHighAI 8/10

Why is Aehr Test Systems stock surging today?

Aehr Test Systems (AEHR) stock surged 18.8% in pre-market trading after reporting record Q1 2027 revenue of $33.0M, up 200% YoY, and raising full-year revenue outlook to $150M. Non-GAAP net income was $9.4M, or $0.28 per share, exceeding analyst estimates. The company cited strong demand for AI semiconductor test solutions and a book-to-bill ratio of 1.4.

$AEHRMed

Aehr stock jumps on beat and raise amid AI demand

Aehr Test Systems (AEHR) shares rose 15% after reporting Q1 revenue of $33M, up 200% YoY, and raising its FY2027 outlook to $150M. The company cited strong demand for its semiconductor testing systems used in AI chips. CEO Gayn Erickson noted a conservative approach to the revised target. Bookings were $46.7M with a book-to-bill ratio of 1.4.